This book is not about convincing people to be better. You've been trying that for six thousand years and it hasn't worked
once. This is about building a system where doing well and doing good are the same thing.
The current system pays for death and disease. The new system pays for life and health.
You can align major interest groups behind a single goal: curing disease.
Not through charity. Not through guilt. Through pure profit.
Moral appeals are for species that respond to moral appeals.
Yours responds to money. Defense Contractors: Teaching Merchants of Death to Love Life.
Defense lobbyists spend one hundred twenty-seven million dollars on lobbying.
They get one hundred eighty-one billion dollars in government contracts back.
That's a one thousand eight hundred ten to one R.O.I. Better returns than any hedge fund in history, and all you have to
do is help kill strangers. They will oppose any treaty that threatens this.
Not because they're evil (though that helps), but because murder is profitable and they like money.
Lobbyists are like pigeons. They go where the food is. Currently the food is in opposing the treaty.
You could try convincing them that saving lives is noble. Or you could just move the food.
It's like convincing a vampire to open a blood bank; counterintuitive but mathematically sound.
The Offer. VICTORY Incentive Alignment Bonds paying two hundred seventy-two percent annually (vs their current salary or
stock options). Early access (get rich before everyone else).
"Consulting fees" (legal bribery has a name). Strategic advisor positions (fake job, real money).
The Math. Their current job (lobbying against treaty). Pay is five hundred thousand dollars to two million dollars per year.
Job security depends on military budget staying huge. Legacy is "Made orphans for money".
Your offer (lobbying for treaty). Pay is five million to twenty million dollars in bonds.
Returns are two hundred seventy-two percent annually, forever.
Job security is better (ninety-nine percent of military budget still exists).
Legacy is "Accidentally saved humanity while getting rich".
Most people can do this math. You hope. Why They Take It. Two hundred seventy-two percent is greater than whatever they're
making now. That's it. That's the whole reason. The treaty doesn't actually hurt them.
Military budget drops one percent (from two point seven two trillion dollars to two point six nine trillion dollars).
They still have ninety-nine percent to protect. Defense contracts still flow.
Jobs stay. Wars probably still happen (just one percent fewer wars, which is still too many wars).
You're asking them to accept slightly less murder funding in exchange for becoming extremely wealthy.
"I support life-saving medical research" sounds better at dinner parties than "I lobby for bombs."
Their kids might even respect them. Probably not, but maybe.
Add ten percent VICTORY bonds to a pension portfolio and blended returns jump from seven percent to thirty-three percent
plus. It's like finding money in the pocket of pants you're currently wearing.
Except the money multiplies. While you're wearing the pants.
Once Lockheed buys bonds, Raytheon has to follow or get crushed by Lockheed's superior returns.
It's a prisoners' dilemma where cooperation pays better than defection.
Start with pension funds (fiduciary duty requires best returns).
They end up lobbying FOR the treaty to protect their investment.
The Flip. Once enough key players flip, momentum shifts. Nobody wants to be the last holdout.
Not while a treaty gains momentum and everyone else gets rich.
It's like a bank run, except instead of withdrawing money, they're depositing principles.
Whether "enough" is ten or fifty or one hundred, nobody knows.
This has never been tried before. But the theory seems sound, assuming humans behave like humans usually do.
Now they don't just stop opposing. They actively lobby FOR it: testifying to Congress that "this strengthens national security"
(technically true: healthy soldiers fight better), writing op-eds about how "a strong military requires a healthy population"
(also true: can't draft corpses), and convincing other lobbyists to flip.
What You're NOT Asking. You're NOT asking them to close factories, lay off workers, stop making weapons, convert to medical
equipment, change their business model, or feel bad about anything.
You're ONLY asking them to accept higher returns on investment, stop blocking the treaty, and maybe say nice things about
it publicly. That's it. They keep ninety-nine percent of their current income PLUS get rich from bonds.
Why This Works. You're using their own playbook. Defense contractors spend one hundred twenty-seven million dollars on lobbying
and get one hundred eighty-one billion dollars back. You're offering them BETTER returns to lobby for something else.
It's not revolutionary. It's just capitalism but pointed at diseases instead of humans.
It's all legal. VICTORY Incentive Alignment Bonds are legal investment vehicles.
Lobbying is protected free speech. Consulting fees are standard practice.
Strategic advisor positions are completely normal (if "normal" means "legal corruption").
They designed the system to allow this. You're just using it correctly.
The same incentive structures that created the military-industrial complex get pointed at curing disease instead.
Like a very expensive garden hose. No moral evolution required.
Just different math. This is either brilliant or ridiculous.
Possibly both. Defense Contractor C.E.O. (to board): "We diversified into bonds paying two hundred seventy-two percent returns
vs the market's ten percent. If the treaty passes, we profit enormously.
If it fails, we still have our defense contracts. It's a hedge.
I'm being prudent. You're welcome.". Budget: Strategic allocation from the one billion dollars incentive alignment budget.
The Timeline. Optimistic (if this works): Key lobbyists flip in months one to twelve.
Defense contractor trade associations go neutral by month eighteen.
By month twenty-five, former opponents take credit: "I always cared about medical research" (they discovered this yesterday).
Pessimistic (if this doesn't work): You and everyone you've ever loved slowly deteriorate into dust.
You can't fight the military-industrial complex. It's too big.
Too entrenched. Too profitable. But you might be able to buy it.
Insurance Companies: The Accidentally Aligned Industry. Insurance companies are already on your side.
They just don't know it yet, because nobody at an insurance company has ever had an original thought.
Every disease you cure is billions they don't have to pay out.
Their Current Death Spiral. Medical costs are rising seven percent annually.
Premiums can't keep pace (regulation). Claims are destroying margins.
Chronic disease leads to lifetime payouts. Their business model is dying.
Your Salvation Offer. The Math They Can't Refuse. Diabetes currently costs three hundred twenty-seven billion dollars annually,
which would drop to a one-time cure cost and a ninety percent reduction in ongoing savings.
Alzheimer's costs three hundred fifty-five billion dollars annually, which would drop to a one-time cure cost and a ninety
percent reduction in ongoing savings. Heart Disease costs three hundred sixty-three billion dollars annually, which would
drop to a one-time cure cost and a ninety percent reduction in ongoing savings.
Cancer costs two hundred eight billion dollars annually, which would drop to a one-time cure cost and a ninety percent reduction
in ongoing savings. Even partial cures dramatically improve their margins.
They don't need zero dollar costs. They just need costs to stop rising seven percent annually, which is currently the speed
at which their business model is committing suicide. The Implementation.
They buy VICTORY Incentive Alignment Bonds with two hundred seventy-two percent returns.
They lobby for the treaty (protects investment). Cures reduce their claims and profits increase.
They lower premiums (competitive advantage). A healthier population results in a permanent profit increase.
Why They're Your Natural Allies. Insurance companies are the only industry that profits from human health.
Every other healthcare player profits from sickness. Use this natural alignment: Pharma wants chronic patients, while insurance
wants cures. Hospitals want full beds, while insurance wants empty ones.
Doctors want repeat visits, while insurance wants one-time fixes.
You're offering insurance companies a world where chronic disease costs stop compounding at seven percent annually.
Pharmaceutical Companies: Converting Drug Dealers to Drug Curers.
Pharma companies aren't evil. They're just doing what any rational organism does when you pay it to keep people sick: keeping
people sick. They're trapped in a business model that rewards treating symptoms forever instead of curing diseases once.
Here's how you free them from their golden cage. Their Current Trap.
R. and D. costs: two point six billion dollars per drug (unsustainable).
Success rate: one in ten thousand compounds work (lottery odds).
Timeline: seventeen years to market (patients die waiting).
Patent cliffs: Blockbusters become generics overnight. Public hatred: Martin Shkreli is their poster boy.
The Cost Elimination. Current model (pharma pays for trials): Pharma spends forty-eight thousand dollars or more per trial
participant. Burns cash for seventeen years hoping for approval.
Ninety percent of drugs fail in trials equals money incinerated.
Success means jacking up prices to recover losses. The new model (using decentralized pragmatic trials): Trial cost drops
approximately ninety-eight percent (pragmatic design, existing medical records, no dedicated sites).
Can afford to run one hundred times more trials with same budget.
Success means profit, failure doesn't bankrupt you. The Math That Converts Them.
Current Pharma Economics. Development cost: two point six zero billion dollars.
Success rate: ten percent (ninety percent fail). Average revenue per success: six point seven zero billion dollars.
R.O.I.: one point two percent (Barely profitable!) New System - Cost Elimination.
The main benefit: pragmatic clinical trials become one hundred times cheaper.
How your decentralized institutes of health eliminate trial costs.
Current system: Pharma spends forty-eight thousand dollars per participant on: Dedicated trial sites and staff.
Extensive monitoring and site visits. Custom data collection infrastructure.
Regulatory compliance overhead. A system using your decentralized institutes of health (D.I.H.): Cost drops approximately
ninety-eight percent because: Uses existing medical practices (no dedicated sites).
Patient's regular doctor enrolls them (one-click). Leverages existing electronic health record, or E.H.R., data (no custom
infrastructure). Pragmatic design equals minimal monitoring.
Platform handles regulatory compliance automatically. Result: fifty-thousand-participant trial drops from two point four
billion dollars to under fifty million dollars (regulatory filing, data analysis, platform fees).
Under the current system, you pay two point six zero billion dollars for trials.
In a decentralized trials framework, you pay approximately fifty million dollars for trials (a ninety-eight percent reduction).
In the current system, ninety percent of drugs fail, resulting in a two point three billion dollar loss.
In the new system, failure costs approximately fifty million dollars, which is survivable.
The current system takes ten to seventeen years for development.
The decentralized system takes two to three years. Under the current system, only blockbusters are viable.
In the new system, rare diseases are profitable. The current system involves massive risk.
The new system involves manageable risk per attempt. A decentralized institutes of health network doesn't change whether
drugs work biologically. It changes the economics. You profit from TRYING, not just from SUCCEEDING.
Pharma's New Business Model: Volume Over Blockbusters. The trade-off: Lower revenue per drug, but massively more attempts.
Current model. Chase one billion dollar plus blockbusters. Can only afford approximately ten attempts (each costs two point
six billion dollars). Need huge markets to justify risk. Ten thousand compounds sitting on shelf.
The new decentralized model. Five hundred million dollars per success is profitable (smaller markets work).
Can attempt all ten thousand compounds (failure doesn't bankrupt you).
Rare diseases become gold mines (no competition). One hundred and fifteen times more trials equals one hundred and fifteen
times more shots on goal. How to Get Them Onboard. Start with generic manufacturers: no R and D costs, immediate margin.
Add biotechs: desperate for cash, will try anything. Big pharma follows: can't let competitors have advantage.
Industry transforms: competition shifts from marketing to outcomes.
Politicians: Hacking Democracy's Source Code. Politicians are the simplest organisms in this ecosystem.
Simpler than bacteria. Bacteria at least reproduce usefully.
Politicians want exactly two things: votes and money. You're going to give them both.
Their Current Misery. Fundraising: seventy percent of their time begging for money.
Approval rating: eighteen percent (everyone hates them). Actual power: Near zero (lobbyists write the bills).
Legacy: "That guy who renamed a post office". Job security: One bad tweet from extinction.
Your Political Welfare Program. The Money Pipeline. Treaty supporter: Super PAC funds flow in.
Treaty opponent: Super PAC funds their opponent. It's not corruption, it's free speech (thanks Citizens United!).
The Vote Harvest. Two hundred and eighty million people voting on Wishocracy.
You publish voting records: "Senator X opposes cheaper healthcare".
Their constituents see this in real-time. Support the treaty or face electoral extinction.
The Bipartisan Beauty. This works on everyone: Republicans: "Free market solution!
Cuts government spending!". Democrats: "Universal healthcare access!
Helps the poor!". Libertarians: "Ends F.D.A. tyranny! Personal freedom!".
Socialists: "Destroys Big Pharma monopoly! Power to people!".
Everyone can claim victory because the framing works for each ideology.
Billionaires: Self-Interest Meets Self-Preservation. Billionaires have everything except the one thing money can't buy:
not dying. A billion dollars and a body that rots at the same rate as everyone else's.
You're offering returns AND longevity research. The incentives align naturally.
What They Really Want. Legacy: Being remembered (narcissism is powerful).
Returns: Beating other billionaires (it's all a game). Survival: Not dying of whatever will kill them.
Reputation: Not being history's villain. Control: Shaping the future.
Your Irresistible Package. The Investment. VICTORY Incentive Alignment Bonds offer returns funded by treaty revenue.
Beats traditional portfolio yields. The Legacy. "The Gates Cancer Center" (permanent naming rights).
"The Musk Longevity Institute" (feed that ego). History books: "Funded the cure for death".
Nobel Peace Prize possible (they crave validation). The Insurance.
They're getting old (mortality is calling). Their genetics aren't special (death doesn't care about wealth).
Every disease cured equals their lifespan extended. Basically buying protection from biology.
The Domino Effect: How This Cascade Works. Once you align a few key players, others follow: The Sequence.
One. Insurance companies move first (pure financial logic).
Two. Their lobbying convinces politicians (money talks). Three.
Politicians create treaty momentum (votes follow). Four. Defense contractors hedge (can't risk being left out).
Five. Pharma pivots (adapt or die). Six. Billionaires pile in (FOMO is powerful).
Why This Can Work: Solving the Collective Action Problem. Public choice theory (a branch of economics devoted to explaining
why nothing good ever happens) predicts that concentrated interests (defense contractors, pharma incumbents) beat diffuse
interests (patients, taxpayers). Small groups with high per-person stakes outorganize large groups with low per-person stakes.
Ten lobbyists who each make ten million dollars from war will always outfight ten million patients who each lose ten dollars
from disease. The current system persists despite its inefficiency.
Or rather, because of it. But here's what Olson missed: The capital asymmetry is ninety to one in favor of diffuse beneficiaries.
Concentrated interests interests like defense and fossil fuels have a market cap of approximately five trillion dollars
and spend one hundred million to one billion dollars annually on politics.
Diffuse beneficiaries, meaning everyone who would benefit from cures, have four hundred fifty-four trillion dollars in household
wealth but spend approximately zero dollars due to coordination failure.
The problem isn't resources. It's coordination. Diffuse beneficiaries can't deploy their ninety to one capital advantage.
Each individual's stake is small. Coordination costs are prohibitive.
Incentive Alignment Bonds, or I.A.B.s, solve the coordination problem by securitizing political change.
Political outcomes become an investable asset class with one hundred to one thousand times expected returns.
Coordination happens through financial markets instead of grassroots organizing.
Investors don't need to care about curing disease. They need to care about returns.
The mechanism converts self-interest into collective action.
Why the cascade can happen (not "must" happen). Once I.A.B.s concentrate financial benefits on the pro-health side: Politicians
face a new calculation where I.A.B. benefits are greater than concentrated opposition costs.
Each policy success increases I.A.B. funding, which strengthens the coalition.
Investors lobby for treaty expansion to increase their returns.
The dynamic reverses: supporting pragmatic clinical trial funding becomes the concentrated-benefit option.
This isn't inevitable. It requires sufficient I.A.B. funding to overcome opposition.
But it's achievable because the capital is there. It just needs a coordination mechanism.
Why This Scales: The Ratchet Effect. Each treaty expansion creates more political incentive funding to lobby for the next
expansion. At one percent, funding is two point seven two billion dollars per year.
At ten percent, it's twenty-seven billion dollars per year.
Politicians who supported the one percent treaty get rewarded.
Those rewards grow if they push for two percent. It's a ratchet that only moves in one direction: the direction where people
stop dying. You've accidentally built ratchets like this before (Social Security, Medicare), but always by accident and
never on purpose. This time, try doing it on purpose. See Incentive Alignment Bonds for the full scaling mechanism and tables.